Interventional for Deep Vein Thrombosis

Sarasota Memorial Hospital, Sarasota, FL
Deep Vein Thrombosis+2 More ConditionsClotTriever System - Device
All Sexes
What conditions do you have?

Study Summary

This trial compares an interventional strategy with anticoagulation therapy to treat iliofemoral DVT to see which is more effective in restoring vessel patency. Results will be collected over 6 months.

Eligible Conditions
  • Deep Vein Thrombosis (DVT)
  • Post-Thrombotic Syndrome
  • Deep Vein Thrombosis

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

0 Primary · 2 Secondary · Reporting Duration: 180 Days (+-14 Days)

Day 10
Composite clinical endpoint constructed as a win ratio, a hierarchy of the following
180 Days (+-14 Days)
Assessment of PTS Severity

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

1 of 2
Conservative Medical Management
1 of 2

Active Control

300 Total Participants · 2 Treatment Groups

Primary Treatment: Interventional · No Placebo Group · N/A

ActiveComparator Group · 1 Intervention: ClotTriever System · Intervention Types: Device
Conservative Medical Management
ActiveComparator Group · 1 Intervention: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 180 days (+-14 days)

Who is running the clinical trial?

Inari MedicalLead Sponsor
9 Previous Clinical Trials
2,851 Total Patients Enrolled
1 Trials studying Deep Vein Thrombosis
500 Patients Enrolled for Deep Vein Thrombosis
Steven Abramowitz, MDPrincipal InvestigatorMedStar Health Research Institution
Xhorlina Marko, MDPrincipal InvestigatorBeaumont Dearborn Hospital
Stephen Black, MDPrincipal InvestigatorSt Thomas' Hospital (UK)
2 Previous Clinical Trials
272 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You started experiencing symptoms within 12 weeks before joining the study.

Frequently Asked Questions

Are there vacancies remaining in this trial for participants?

"Affirmative. Based on the information available through, this research project is currently recruiting patients, and it was first posted on January 6th of 2023 with a most recent update being published on the 18th of that same month. This trial requires 300 participants across two different sites to be enrolled in order for completion." - Anonymous Online Contributor

Unverified Answer

What is the current enrollment count for this investigation?

"Affirmative. According to the information on, recruitment for this medical trial is ongoing and began on June 1st 2023; it was revised as recently as January 18th of 2022. The study requires 300 participants from two separate sites." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.